Mortality | ||||||
---|---|---|---|---|---|---|
Unadjusted | Adjusted | |||||
HR | 95% CI | P | HR | 95% CI | P | |
Gender | ||||||
Male | 1.0 | |||||
Female | 1.0 | (0.6-1.7) | 0.863 | 1.3 | (0.7-2.2) | 0.399 |
Age | ||||||
≤35 years | 1.0 | |||||
>35 years | 1.2 | (0.7-2.0) | 0.430 | 1.6 | (0.9-2.8) | 0.107 |
Baseline CD4 count | ||||||
≤100 cells/μl | 1.0 | |||||
>100 cells/μl | 0.5 | (0.3-0.9) | 0.025 | 0.8 | (0.5-1.5) | 0.556 |
KS Stage | ||||||
T0 | 1.0 | |||||
T1 | 3.5 | (1.8-6.8) | <0.001 | 5.3 | (2.7-10.6) | <0.001 |
S0 | 1.0 | |||||
S1 | 5.7 | (1.8-18-1) | 0.003 | 5.1 | (1.5-17.0) | 0.008 |
cART | ||||||
Yes | 1.0 | |||||
No | 1.5 | (0.8-2.8) | 0.172 | 1.4 | (0.7-2.8) | 0.355 |
Chemotherapy | ||||||
Yes | 1.0 | |||||
No | 1.2 | (0.7-2.2) | 0.482 | 2.4 | (1.2-4.8) | 0.012 |
Radiation Therapy | ||||||
Yes | 1.0 | |||||
No | 1.3 | (0.7-2.3) | 0.398 | 1.1 | (0.6-2.1) | 0.668 |